July 11 (Reuters) - Xvivo Perfusion AB XVIVO.ST:
XVIVO Q2 EBIT SEK 7.1 MILLION
XVIVO Q2 EPS SEK 0.05
XVIVO Q2 NET INCOME SEK 1.6 MILLION
XVIVO Q2 ADJUSTED EBIT SEK 6.8 MILLION
XVIVO Q2 SALES SEK 178.3 MILLION
XVIVO PERFUSION AB - CONTINUE TO SEE STRONG SALES GROWTH IN LUNG AMONG US CUSTOMERS
XVIVO PERFUSION AB - SEE CONTINUED STRONG INTEREST IN INVESTING IN NEW EVLP AND LIVER PERFUSION PROGRAMS
Source text: ID:nMFN4C6Ktq
Further company coverage: XVIVO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))